This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The RealReal Reports Narrower-Than-Expected Q3 Loss, Raises 2024 View
by Zacks Equity Research
REAL posts Q3 2024 results with an 11% revenue increase and a 6% rise in GMV. The company raises its 2024 guidance.
Is Stride (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Here is how K12 (LRN) and The RealReal (REAL) have performed compared to their sector so far this year.
Zacks.com featured highlights include TAL Education, The RealReal, DarioHealth, HealthEquity and Energous
by Zacks Equity Research
TAL Education, The RealReal, DarioHealth, HealthEquity and Energous have been highlighted in this Screen of The Week article.
Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios. These stocks include TAL Education Group (TAL), The RealReal (REAL), DarioHealth (DRIO), HealthEquity (HQY) and Energous (WATT).
Is The RealReal (REAL) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how The RealReal (REAL) and Reservoir Media, Inc. (RSVR) have performed compared to their sector so far this year.
The RealReal (REAL) Loses -7.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The RealReal (REAL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Is Kontoor Brands (KTB) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how Kontoor Brands (KTB) and The RealReal (REAL) have performed compared to their sector so far this year.
The RealReal (REAL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
The RealReal (REAL) delivered earnings and revenue surprises of 13.33% and 3.64%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The RealReal (REAL) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
The RealReal (REAL) delivered earnings and revenue surprises of 14.29% and 3.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Has Gildan Activewear (GIL) Outpaced Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Here is how Gildan Activewear (GIL) and The RealReal (REAL) have performed compared to their sector so far this year.
Should You Buy The RealReal (REAL) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
What Makes The RealReal (REAL) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does The RealReal (REAL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is American Woodmark (AMWD) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how American Woodmark (AMWD) and The RealReal (REAL) have performed compared to their sector so far this year.
The RealReal, Inc. (REAL) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
The RealReal (REAL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Fast-paced Mover The RealReal (REAL) Is a Great Choice for Value Investors
by Zacks Equity Research
The RealReal (REAL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Compared to Estimates, The RealReal (REAL) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for The RealReal (REAL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The RealReal (REAL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
The RealReal (REAL) delivered earnings and revenue surprises of 36.36% and 0.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Gear Up for The RealReal (REAL) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for The RealReal (REAL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Snap-on (SNA) Looks Well Placed on RCI Initiative & Cost Plans
by Zacks Equity Research
Snap-on (SNA) is poised for growth on positive business momentum, RCI initiative and contributions from its Value Creation plan.
4 Solid Stocks to Buy as Inflation Continues to Cool
by Ritujay Ghosh
Virco Mfg (VIRC), Comcast (CMCSA), Warner Music Group (WMG) and The RealReal (REAL) are likely to benefit from the steady decline in inflation.
Growth Initiatives to Aid Spectrum Brands (SPB): Stock to Gain
by Zacks Equity Research
Spectrum Brands (SPB) looks poised for the long-term on promising growth initiatives and efficient cost management amid a tough macro environment.
Central Garden & Pet (CENT) Displays Solid Prospects Amid Risks
by Zacks Equity Research
Central Garden & Pet (CENT) is poised to benefit from strength in its Pet segment, portfolio sterilization and Central-to-Home strategy. High costs and expenses remain a concern.
Here's What Key Metrics Tell Us About The RealReal (REAL) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for The RealReal (REAL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Industry Outlook Highlights Central Garden & Pet, Alto Ingredients, The RealReal and Lifetime Brands
by Zacks Equity Research
Central Garden & Pet, Alto Ingredients, The RealReal and Lifetime Brands are part of the Zacks Industry Outlook article.
4 Stocks to Watch in a Challenging Consumer Products-Discretionary Industry
by Sumit Singh
Central Garden & Pet Company (CENT), Alto Ingredients (ALTO), The RealReal (REAL) and Lifetime Brands (LCUT) focus on a superior product strategy and prudent capital investments.